GLP-1 year two cost effectiveness study abstract

The event emphasizes additional measures for obesity therapy.

publications Quarterly Drug Pipeline: October 2025 Clinical insights and competitive intelligence on anticipated drugs in development October 30, 2025 Editor-in-chief's message Welcome to the Prime...

Forbes

Prime Therapeutics researchers share more about award-winning real-world research

Pharmacy Practice News, originally published by Specialty Pharmacy Continuum

BioSpace: As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health outcomes—evidenced by successful studies in therapeutic areas like...

As demand for GLP-1a drugs for weight loss has increased, new data provides additional insights about this new class of medications.

publications Quarterly Drug Pipeline: July 2024 Clinical insights and competitive intelligence on anticipated drugs in development Editor-in-chief's message Welcome to the Prime Quarterly Drug...

Quarterly Drug Pipeline: April 2024 Clinical insights and competitive intelligence on anticipated drugs in development Drug Pipeline Clinical insights and competitive intelligence on anticipated...